Jason Patrick Meyenburg - Net Worth and Insider Trading

Jason Patrick Meyenburg Net Worth

The estimated net worth of Jason Patrick Meyenburg is at least $544,104 dollars as of 2024-04-19. Jason Patrick Meyenburg is the Chief Commercial Officer of Sucampo Pharmaceuticals Inc and owns about 30,228 shares of Sucampo Pharmaceuticals Inc (SCMP) stock worth over $544,104. Details can be seen in Jason Patrick Meyenburg's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jason Patrick Meyenburg has not made any transactions after 2017-09-06 and currently still holds the listed stock(s).

Transaction Summary of Jason Patrick Meyenburg

To

Jason Patrick Meyenburg Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jason Patrick Meyenburg owns 1 companies in total, including Disc Medicine Inc (IRON) .

Click here to see the complete history of Jason Patrick Meyenburg’s form 4 insider trades.

Insider Ownership Summary of Jason Patrick Meyenburg

Ticker Comapny Transaction Date Type of Owner
IRON Disc Medicine Inc 2021-05-14 director & President & CEO

Jason Patrick Meyenburg Latest Holdings Summary

Jason Patrick Meyenburg currently owns a total of 1 stock. Jason Patrick Meyenburg owns 30,228 shares of Sucampo Pharmaceuticals Inc (SCMP) as of September 6, 2017, with a value of $544,104.

Latest Holdings of Jason Patrick Meyenburg

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SCMP Sucampo Pharmaceuticals Inc 2017-09-06 30,228 18.00 544,104

Holding Weightings of Jason Patrick Meyenburg


Jason Patrick Meyenburg Form 4 Trading Tracker

According to the SEC Form 4 filings, Jason Patrick Meyenburg has made a total of 0 transactions in Sucampo Pharmaceuticals Inc (SCMP) over the past 5 years. The most-recent trade in Sucampo Pharmaceuticals Inc is the acquisition of 4,000 shares on September 6, 2017, which cost Jason Patrick Meyenburg around $48,520.

Insider Trading History of Jason Patrick Meyenburg

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jason Patrick Meyenburg Trading Performance

GuruFocus tracks the stock performance after each of Jason Patrick Meyenburg's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jason Patrick Meyenburg is 20.76%. GuruFocus also compares Jason Patrick Meyenburg's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jason Patrick Meyenburg within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Jason Patrick Meyenburg's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Jason Patrick Meyenburg

Average Return

Outperforming Transactions

Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -14.94 20.76
Relative Return to S&P 500(%) -18.34 14.12

Jason Patrick Meyenburg Ownership Network

Ownership Network List of Jason Patrick Meyenburg

No Data

Ownership Network Relation of Jason Patrick Meyenburg


Jason Patrick Meyenburg Owned Company Details

What does Disc Medicine Inc do?

Who are the key executives at Disc Medicine Inc?

Jason Patrick Meyenburg is the director & President & CEO of Disc Medicine Inc. Other key executives at Disc Medicine Inc include 10 percent owner Atlas Venture Fund X, L.p. , director & 10 percent owner Orbimed Advisors Llc , and director & 10 percent owner Mona Ashiya .

Disc Medicine Inc (IRON) Insider Trades Summary

Over the past 18 months, Jason Patrick Meyenburg made no insider transaction in Disc Medicine Inc (IRON). Other recent insider transactions involving Disc Medicine Inc (IRON) include a net sale of 1,106,612 shares made by Atlas Venture Fund X, L.p. , a net sale of 297,652 shares made by Kevin Bitterman , and a net sale of 20,634 shares made by Joanne Bryce .

In summary, during the past 3 months, insiders sold 281,217 shares of Disc Medicine Inc (IRON) in total and bought 0 shares, with a net sale of 281,217 shares. During the past 18 months, 3,922,166 shares of Disc Medicine Inc (IRON) were sold and 652,175 shares were bought by its insiders, resulting in a net sale of 3,269,991 shares.

Disc Medicine Inc (IRON)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Disc Medicine Inc Insider Transactions

No Available Data

Jason Patrick Meyenburg Mailing Address

Above is the net worth, insider trading, and ownership report for Jason Patrick Meyenburg. You might contact Jason Patrick Meyenburg via mailing address: C/o Sucampo Pharmaceuticals, 805 King Farm Boulevard, Suite 550, Rockville Md 20850.

Discussions on Jason Patrick Meyenburg

No discussions yet.